Why is Themis Medicare falling/rising?

As of 11-Jul, Themis Medicare Ltd is currently priced at 124.20, reflecting a decrease of 0.1 or 0.08%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 4.42% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The stock's performance over the past week shows a decline of 0.60%, while its one-month return is significantly worse at -14.93%. The company has also reported a substantial drop in net sales and profits, with a year-over-year return of -46.14%, indicating ongoing financial struggles. Furthermore, the lack of domestic mutual fund investment suggests a lack of confidence in the stock's future performance.
In the broader market context, Themis Medicare's short-term performance has been worse than the benchmark Sensex, which has seen a decline of 1.12% over the same week. The company's negative results over the past two quarters, along with a significant drop in investor participation and liquidity, contribute to its poor market sentiment. Despite a relatively strong ability to service debt and a fair valuation compared to peers, the stock's long-term growth prospects appear weak, as indicated by a low operating profit growth rate and a negative return on capital employed. This combination of factors has led to a lack of investor confidence, further driving the stock's decline.